Status:
COMPLETED
Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
Lead Sponsor:
University of Minnesota
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This r...
Detailed Description
OBJECTIVES: * Measure plasma cathepsin D levels in patients with non-small cell lung cancer and in healthy volunteers using mass spectometry. * Measure fatty acid synthase levels in these patients an...
Eligibility Criteria
Inclusion
- Non-Small Cell Lung Cancer Patients
- Documented diagnosis of non-small cell lung cancer, any stage and any time point in the course of treatment (i.e., at diagnosis, during any treatment, and during post treatment surveillance)
- Measurable disease by CT scan within the past 4 weeks
- Healthy volunteer
- Non-smoking, defined as \< 5 packs/year history of smoking and cessation of smoking ≥ 6 months ago OR a never smoker
- Not regularly exposed (i.e., daily) to second-hand smoke
Exclusion
- Severe underlying lung disease (i.e., chronic obstructive pulmonary disease with FEV\_1 \< 1.0 L, pulmonary fibrosis, bronchiectasis, cystic fibrosis, etc.) as determined by enrolling researcher.
- Written consent must be given for both subjects and controls.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00897234
Start Date
December 1 2008
End Date
October 1 2010
Last Update
August 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States, 55455